Intervention

Smoking Cessation

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials6

Recruiting0

Common conditions17

Lead sponsors shown6

Clinical trials

6 shown

Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scanNCT06293833 · 2024-09-01

UNKNOWN

Undiagnosed COPD and Asthma Population Study (UCAP)NCT03148210 · 2017-06-05

COMPLETED

Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive PatientsNCT00689819 · 2008-10-01

COMPLETED

Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)NCT00933595 · 2007-09-01

COMPLETED

Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With DiabetesNCT00233259 · 2006-03-01

COMPLETED

Strategies to Reduce Weight Gain in Hypertensive SmokersNCT00119821 · 2004-09-01

COMPLETED

Common conditions

Cardiovascular Diseases2 Heart Diseases2 Hypertension2 Asthma1 COPD1 Diabetes Mellitus, Type 21 Diastolic Dysfunction1 High Blood Pressure1 HIV Infections1 Lung Cancer1 Lung Cancer, Nonsmall Cell1 Lung Cancer, Small Cell1 Obesity1 Pulmonary Complications1 Smoking Cessation1 Systolic Dysfunction1 Ventricular Hypertrophy1

Leading sponsors

National Heart, Lung, and Blood Institute (NHLBI) 1 Oregon Research Institute 1 Ottawa Hospital Research Institute 1 University Hospital, Antwerp 1 University of Tennessee 1 Wayne State University 1

Trial status mix

COMPLETED5

UNKNOWN1

Phase mix

NA6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.